David Fractor

David Fractor is an experienced financial executive with a strong background in CFO roles across various companies, including ImaginAb and ImmunoCellular Therapeutics Ltd, where significant accomplishments include facilitating capital raises and uplisting to NYSE American. David Fractor also runs a consulting firm offering interim CFO and controller services, catering to organizations seeking cost-effective financial leadership. Previous positions include CFO at HemaCare Corporation, where David Fractor developed a mobile blood program and managed SEC filings, and CFO at Andwin Corporation, where innovative financial strategies were implemented. Early in the career, David Fractor served as an Audit Manager at Deloitte. David Fractor holds a BS in Accounting and Finance from USC Marshall School of Business.